Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$104,202,054
+$47,337,298 QoQ
Shares Held
383,872
+35.0% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#61
of 844 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $537,568,705 across 6 Diagnostics & Research names. NTRA ranks #3 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
1,533,985 | $230,143,769 | |
| 2 | TWST |
Twist Bioscience Corp
|
1,022,526 | $105,197,474 | |
| 3 | NTRA |
Natera, Inc.
This page
|
383,872 | $104,202,054 | |
| 4 | VCYT |
Veracyte, Inc.
|
1,045,826 | $61,421,360 | |
| 5 | NEO |
Neogenomics Inc
|
2,508,845 | $36,604,048 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
631,926 | $0 |
All Filings in NTRA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $104,202,054 | 383,872 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,864,756 | 284,338 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $143,390,180 | 625,912 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $94,355,462 | 586,168 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $166,423,638 | 985,105 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $133,573,623 | 944,584 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $146,118,023 | 923,045 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $112,062,446 | 882,729 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $132,196,966 | 1,220,768 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $97,401,790 | 1,064,966 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,229,039 | 706,083 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,555,250 | 713,113 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,978,223 | 554,423 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $24,603,465 | 443,146 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,938,748 | 98,052 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,368,558 | 54,052 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $35,130,142 | 376,166 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $101,134,920 | 907,528 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $89,760,791 | 790,635 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $78,306,124 | 771,185 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $82,047,970 | 824,437 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $57,589,655 | 797,199 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $38,909,298 | 780,371 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $22,586,104 | 756,400 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||